Your browser doesn't support javascript.
loading
[Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients].
Liu, X L; Yang, P Y; Yu, X Y; Chen, J C; Liu, X L; Bai, J; Liu, Y M; He, H; Sun, J N; Fan, H Q; Zhang, C; Zhang, Y; Su, K J; Liu, C S; Tan, Y H; Gao, S J; Li, W; Jin, F Y.
Affiliation
  • Liu XL; Department of Hematology, Cancer Center, the First Hospital of Jilin University, Changchun 130012, China.
Zhonghua Xue Ye Xue Za Zhi ; 39(5): 408-413, 2018 May 14.
Article in Zh | MEDLINE | ID: mdl-29779352
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Aberrations / Bortezomib / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2018 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosome Aberrations / Bortezomib / Multiple Myeloma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2018 Document type: Article Affiliation country: China Country of publication: China